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Error in DEHP Background
Concentration
In the May 1998 issue of Environmental
Health Perspectives, Woodruff et al. (1)
reported an analysis conducted as part of
the U.S. Environmental Protection Agency
(EPA) Cumulative Exposure Project
(CEP). The EPA modeled air concentra-
tions of chemicals listed in the Clean Air
Act as hazardous air pollutants (HAPs) in
over 60,000 census tracts and compared
those concentrations to health benchmarks.
The Phthalate Esters Panel ofthe Chemical
Manufacturers Association has become
aware of an error in the background con-
centration value used for bis(2-ethylhexyl)
phthalate (DEHP), with the result that
modeled air concentrations for DEHP-
and thus the potential health hazard-were
greatly exaggerated.
Woodruff et al. (1) reported, "Eight
pollutants ... [including DEHP] had mod-
eled concentrations exceeding the bench-
mark concentrations for cancer in 100% of
the census tracts. For each of these HAPs,
the background concentration alone ...
exceeded the benchmark concentration for
cancer, as shown in Table 2." Their Table
2 (1) shows that the background concentra-
tion used for DEHP was 1.6 pg/m3. That
value was taken from Howard (2) who
reported "mean remote ocean air concen-
trations" for DEHP of 0.07-0.17 ppb, cit-
ing Atlas and Giam (3). However, Atlas
and Giam (3) actually reported remote
DEHP air concentrations to be 0.32-2.68
ng/m3, with a mean of 1.4 ng/m3 a value
more than 1,000 times less than the back-
ground value used for the CEP analysis.
The panel has alerted the EPA to this error,
and the EPA accordingly has corrected the
CEP modeling report (4).
TIable 2 of Woodruff et al. (1) shows
that if the erroneous background value of
1.6 pg/m3 is disregarded, the CEP model
predicts DEHP air concentrations to
exceed the health benchmark of 0.25
pg/m3 in only 18 census tracts. Even this
estimate probably exaggerates the potential
health hazard for two reasons. First, to the
panel's knowledge, the highest measured
ambient DEHP air concentration in the
United States that has been reported in the
literature is 28 ng/m3 (5)-an order of
magnitude below the EPA's cancer health
benchmark. Second, the EPA's health
benchmark of 0.25 pg/m3 was derived
using an upper-bound unit risk methodolo-
gy to extrapolate tumor data in rats and
mice to human risk (6,7). However,
numerous investigators now conclude that
peroxisome proliferators such as DEHP
pose little ifany human cancer risk and that
the quantitative risk assessment for such
compounds should be based on a margin of
exposure approach (8-10). This would sig-
nificantly increase the health benchmark
for DEHP and decrease (probably to zero)
the number ofcensus tracts in which mod-
eled air concentrations would exceed the
health benchmark.
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DEHP Correction
We thank Courtney Price for pointing out
an error in the background concentration for
bis(2-ethylhexyl)phthalate (DEHP) in our
paper "Public Health Implications of 1990
Air Toxics Concentrations across the United
States" (1). In this paper, emissions data
from stationary and mobile sources are used
in an atmospheric dispersion model to esti-
mate outdoor concentrations of 148 toxic air
contaminants for each of the 60,803 census
tracts in the contiguous United States.
Outdoor concentrations of air toxics were
compared to previously defined benchmark
concentrations for cancer and noncancer
health effects. Benchmark concentrations are
based on standard toxicological references
and represent air toxic levels above which
health risks may occur.
The results reported for DEHP are
incorrect due to an error in the estimated
background concentration for DEHP. We
had originally used a value of 1.6 pg/m3 for
DEHP, which was reported by Howard
(2). As pointed out by Price, Howard (2)
had incorrectly reported the value from
another source, Atlas and Giam (3).
Consequently, we have revised the back-
ground concentration for DEHP to 0.0014
pg/m3, consistent with the mean value
reported byAtlas and Giam.
We had reported that the background
concentration for DEHP was greater than
the cancer benchmark for DEHP. However,
the revised background concentration is
much lower than the cancer benchmark.
Thus, DEHP should not be included in the
list ofpollutants in Table 2 for which back-
ground concentrations alone exceeded can-
cer benchmark concentrations (1). The
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